Key Record Dates
ClinicalTrials.gov Identifier: | NCT04053322 |
---|---|
Brief Title: | Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients. (DOLAF) |
First Submitted : | August 9, 2019 |
First Submitted that Met QC Criteria : | August 9, 2019 |
First Posted : | August 12, 2019 |
Last Update Submitted that Met QC Criteria : | November 5, 2021 |
Last Update Posted : | November 8, 2021 |